Professor Peter Adams named Mentor of the Year, a new honor from the Institute’s Office of Education, Training and International Services (OETIS) and the Postdoctoral Training Advisory Group (PTAG). The award was announced at the 21st annual Trainee Research Symposium.

Their research has shown promise for tobacco use — now they’re tackling another epidemic

The Board of Directors of Sanford Burnham Prebys is pleased to announce the appointment of David Brenner, M.D., as the Institute’s next president and chief executive officer.

Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss.

Institute researchers have shown for the first time that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth.

A method for studying human neurons could help researchers develop approaches for treating Alzheimer’s, schizophrenia and other neurological diseases

The multi-institution initiative will reveal new insights into the aging process and uncover targets to promote health across the life span

Monarch butterflies were recently declared endangered, so the Institute is planting Milkweed to help support their repopulation.

For the first time, Sanford Burnham Prebys hosted high school interns from the SPARK program, an initiative by the California Institute for Regenerative Medicine (CIRM) that provides biomedical research opportunities for underrepresented groups throughout California.

Timothy Huang, Ph.D., has been awarded $2.8 million by the National Institute on Aging (NIA) to continue his work on Alzheimer’s disease. The four-year project will use human stem cells transplanted into mice to determine the role of specific Alzheimer’s-related gene mutations in the brain. 

This year's Preuss internship program was hosted by the Institue's NCI-designated Cancer Center.

Assistant Professor Jianhua Zhao, Ph.D., has been awarded a unique and competitive NIH grant to study the molecular machinery of protein recycling and discover new targets for cancer therapies.